At a glance
- Originator Nippon Mining
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 26 May 2001 Profile reviewed but no significant changes made
- 20 Mar 1995 No-Development-Reported for HIV infections treatment in Japan (Unknown route)